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phatydylinositol 3-kinase (PI3K) reduced insulin relaxant effect in both LZR 
and OZR. Basal levels of both phospho-Akt Ser473 and Akt were increased in 
arteries of OZR, and insulin increased Akt phosphorylation in both LZR and 
OZR. Moreover, insulin enhanced Akt expression in LZR. Inhibition of the 
ERK mitogen activated protein kinase (MAPK) did not affect the relaxations 
to insulin in either OZR or LZR. Basal levels of phospho-MAPKp42/p44 were 
signi¿ cantly lower in coronary arteries from OZR and palmitic acid signi-
¿ cantly reduced these levels in LZR. Palmitic acid did not affect the endo-
thelium-dependent relaxations to either insulin or acetylcholine in coronary 
arteries nor the increase of eNOS phosphorylations.
Conclusions: Coronary arteries are protected from vascular IR. The results 
underscore the fact that preservation of insulin-mediated vasorelaxation along 
with an up-regulation of the Akt/eNOS pathway and an impairment of the 
MAPK cascade account for this protection. 
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Background: Type 2 diabetes abolished gender differences in premeno-
pausal women and diabetic women have signi¿ cantly higher mortality after 
myocardial infarction than diabetic men but the molecular mechanisms 
involved are not well understood. Here, we have investigated the effect of 
gender on energy metabolism, endothelial function and NO pathway in the 
type 2 diabetic Goto-Kakizaki (GK) rat heart.
Materials and Methods: Age-matched Control Wistar (male n=8, female 
n=5) and GK (male n=8, female n=8) isolated rat hearts were perfused during 
28 min with a physiological Krebs-Henseleit buffer containing 0.4 mM palmi-
tate, 3% albumin, 11 mM glucose, 3U/L insulin, 0.8 mM lactate and 0.2 mM 
pyruvate before freeze-clamping for biochemical assays. ATP, phosphocrea-
tine (PCr) and intracellular pH (pHi) were followed using P31 magnetic reso-
nance spectroscopy with simultaneous measurement of contractile function. 
NO pathway was studied by total nitrate concentration (NOx) as well as 
total level and phosphorylation of eNOS and Akt. In parallel, endothelium- 
dependent and independent vasodilatations were measured in other hearts 
(male Control n=10, male GK n=7, female Control n=5, female GK n=6), 
using 5-hydroxytryptamine and papaverine to assess endothelial and smooth 
muscle function.
Results: Phosphocreatine and ATP contents were not signi¿ cantly different 
in Control and diabetic groups. Myocardial function was signi¿ cantly impaired 
in male and female diabetic versus Control groups (p<0.05). Endothelium-
dependent and independent vasodilatations were not different in male Control 
and GK rat hearts. By contrast, endothelium-dependent and independent vaso-
dilatations were signi¿ cantly impaired in female GK compared with male 
GK rat hearts (p=0.0014 and p=0.024). In addition, NOx content (nmol/mg 
protein) was signi¿ cantly reduced in female GK (0.22±0.01) compared with 
male GK (0.36±0.05) rat hearts (p=0.009).
Conclusion: We reported here an impaired endothelial function associated 
with altered NO pathway in the female GK rat hearts. These results could be 
related to higher risk of cardiovascular disorders in type 2 diabetic female.
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Introduction: The pathogenesis of diabetic cardiomyopathy is not fully elu-
cidated. Numerous factors may contribute to the development of heart failure 
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Aims: Cardiotrophin-1 (CT-1), a member of Interleukine-6 (IL-6) family 
causes insulin resistance in adipocytes. However its effect on glucose meta-
bolism in the heart remains unknown. Thus the aim of this work was to test 
whether CT-1 induces insulin resistance in cultured cardiomyocytes.
Methods: Rat cardiomyocytes were cultured in presence or absence of 
1nM CT-1. Thereafter glucose transport was measured in response to insulin 
or Oligomycin, a mitochondrial ATP synthase inhibitor, used as a surrogate of 
metabolic stress. Intracellular signaling triggered by glucose transport stimuli 
was analyzed by Western-Blot.
Results: Cardiomyocytes stimulated with increasing dose of insulin exhi-
bited a dose response with a maximal response reached at 100nM of insulin. 
However, when treated with CT-1 the response of relative glucose transport 
was markedly reduced at all concentrations of insulin, indicating reduction in 
insulin responsiveness rather than in insulin sensitivity. CT-1 also reduced oli-
gomycin-stimulated glucose transport.
Since stimulation with insulin induces phosphorylation of the signaling 
intermediates Insulin Receptor (IR), Akt, and AS160, we have estimated their 
phosphorylation level by Western-Blot. Phosphorylation of IR, Akt on the resi-
dues Thr308 and Ser473, and AS160 were lower in cardiotrophin-1 treated 
cardiomyocytes.
To explain the mechanism of insulin resistance in cardiomyocytes treated 
CT-1 we hypothesized a role for the pro-inÀ ammatory factor NFkB. In fact, 
phosphorylation of the pro-inÀ ammatory factor was increased in cardiotro-
phin-1 treated cardiac myocytes compare to untreated cardiomyocytes.
Conclusion: Chronic exposure of cardiomyocytes to CT-1 leads to a loss 
in the À exibility of glucose metabolism, by mechanisms that remain to be 
investigated.
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Objective: Since insulin resistance (IR) is an important risk factor for coro-
nary artery disease, the current study was designed to assess whether the vas-
cular effects and the signaling pathways of insulin are impaired in coronary 
arteries of an animal model of genetic obesity/IR.
Research design and methods: Intramyocardial arteries from obese Zucker 
rats (OZR) and their counterparts, lean Zucker rats (LZR), were mounted in 
microvascular myographs to assess the vascular function and phosphorylation 
of proteins of the insulin pathway was determined by Western blotting.
Results: The endothelium-dependent NO-mediated vasorelaxant effect of 
insulin was similar in coronary arteries from LZR and OZR. Basal levels of 
phospho-eNOS Ser1177 were increased in arteries of OZR, and insulin aug-
mented eNOS phosphorylation in both LZR and OZR. Inhibition of phos-
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Fructose predisposes to the development of various cardiovascular diseases 
associated with an impairment of endothelium-dependent vasodilatation.
Semi-chronic administration of fructose to healthy adult men increases 
levels of serum uric acid associated with an rise in blood pressure (BP), and 
these phenomena are prevented by the xanthine oxidase inhibitor, allopurinol 
(ALLO) (1). The aim of the present study was to examine the effects ALLO 
independent of uric acid pathway, on metabolic and cardiovascular parameters 
in fructose-fed rats (FFR), an experimental model of insulin resistance impli-
cated in metabolic syndrome. Wistar rats, received water (control group) or 
fructose (FFR) in drinking water 10% (w/v) during an experimental period 
of 8 weeks. FFR rats had elevated systolic blood pressure, a myocardial dys-
function associated with an elevation of reactive oxygen species (ROS) in 
the heart and a decreased level of nitric oxide (NO) production in the endo-
thelium of thoracic aortas, as mesured by Electron Paramagnetic Resonance 
Spectroscopy. Chronic ALLO administration (50mg.kg-1 per day for 8 weeks) 
reduced systolic blood pressure (FFR 122±4 and ALLO 97±2 mmHg), left 
ventricular (LV) relaxation constant tau (FFR 5.63±0.9 and ALLO 3.17±0.1 
ms), LV end-diastolic pressure (FFR 4.55±0.9, ALLO 1.03±0.5 mm Hg), 
and tended to reduce the mitochondrial (FFR 62.9±10.8, ALLO 42.5±3.0 
M.mg-1) ROS production. Furthermore, ALLO restored the NO production 
in thoracic aortic segments. We conclude that xanthine oxidase plays a role 
independent from the acid uric, since rats possess the enzyme uricase, LV dys-
function observed in metabolic syndrome.
(1) SE Perez-Pozo, et al. International Journal of Obesity (2010) 34, 454-461;
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Background: Abdominal obesity is associated with low concentrations of 
HDL-cholesterol and with the presence of small, dense HDL and LDL par-
ticles. Low concentrations of adiponectin and low grade inÀ ammation are bio-
logical features of abdominal obesity.
Objective: The aim of our study was to determine the inÀ uence of adipo-
nectin on the repartition of HDL and LDL subfractions as well as inÀ amma-
tory biomarkers in this population.
Design: We studied 87 patients with body mass index (BMI) >25 kg/m². 
All patients underwent routine clinical and biological evaluation, including 
lipid and apolipoprotein analysis. Total adiponectin, high sensitivity C-reactive 
protein and lipoprotein-associated phospholipase A2 were measured. After 
lipoprotein isolation by ultracentrifugation, HDL and LDL subfractions were 
isolated by gradient gel electrophoresis and their distribution quanti¿ ed. 
Serum concentration of LpA-I and LpA-I:A-II lipoparticles was determined 
by electroimmunodiffusion.
in a diabetic context, including the scarcity of microvasculature and neuro-
humoral dysregulation, particularly the renin-angiotensin-aldosterone-system. 
We have previously shown that a modest increase of intracardiac aldosterone 
prevents the development of cardiomyopathy in mice with type 1 diabetes, 
possibly through a prevention of cardiac capillary dropout (Messaoudi et al, 
Faseb J 2009). This study aimed to determine the effects of aldosterone in the 
heart of mice with type 2 diabetes (T2D).
Materials and methods: 3 week-old mice, overexpressing aldoste-
rone synthase (AS), n=9 and their littermate (WT) n=5 were fed a high fat, 
high sucrose diet (HFHSD: 41% fat, 43% carbohydrate) or a standard diet 
ad libitum. After 4 month diet, glucose and insulin tolerance tests were per-
formed. Echocardiography was done, mice were sacri¿ ced and tissue samples 
were used for RT-PCR and histological analyses.
Results: After 4 months of HFHSD, WT and AS mice had diabetes (D) 
signs: both WT-D and AS-D mice had hyperglycemia (+55%, 56%, P<0.05 
vs WT and AS, respectively), body overweights (+20%, P<0.001;+30%, 
P<0.05 vs WT and AS, respectively). An altered response to both glucose 
and insulin injection was observed in WT-D mice, indicating that these mice 
were insulin resistant and glucose intolerant. Surprisingly, AS-D mouse res-
ponses to hyperglycemia tests were unaltered. Echocardiography did not show 
any cardiac dysfunction. The RT-PCR results revealed an increase in expres-
sion of the markers of oxidative stress and inÀ ammation in WT-D group only. 
Interestingly, VEGFa and insulin receptor substrate 1 (IRS1) mRNAs were 
upregulated in AS-D mice (+44%, P<0.05; +20% P<0.05 vs AS). Besides, 
NOS3 (Nitric Oxide Synthase 3) and IRS2 increased in both diabetic group.
Conclusion: The results indicated that mice developing T2D for 4 months 
did not exhibit cardiac dysfunction. Moderate hyperaldosteronism seems to 
counteract in part the T2D development in mice; the roles of AKT pathway 
remain to be clearly demonstrated.
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Background: Cardiovascular risk is more severe in hypercholestero-
lemic hypertensive subjects with than without diabetes mellitus type 2 and 
is expected to differ in terms of pulsatile arterial hemodynamics including 
pulse wave velocity (PWV), wave reÀ ections (WR), pulse pressure ampli¿ -
cation (PPA).
Material and methods: Hypertensive subjects were divided into 2   groups 
for the same age, sex, heart rate, and mean blood pressure (MBP > 105mmHg) 
including 216  non diabetic and 122 diabetic subjects with 51 under and 71 
without insulin treatment. Pulse wave analysis was performed in all patients.
Results: PWV was markedly higher (P< 0.001) in diabetic than in non- dia-
betic subjects with, in the former group, a signi¿ cantly higher ß index value 
relating PWV to pulse pressure. WR was signi¿ cantly lower in diabetic than 
in non- diabetic subjects. Under insulin treatment, PWV, but not WR and PPA, 
was increased signi¿ cantly.
Conclusion: Diabetic subjects have more severe pulsatile arterial hemody-
namics than non-diabetic subjects for the same MAP, i.e. with higher PWV, 
lower WR and unchanged PPA, resulting in a more severely disturbed cardiac 
function. Insulin treatment and PWV, but not WR and PPA, are positively 
associated. (n=186)
Key words: hypertension, diabetes type2, insulin, arterial stiffness, wave 
reÀ ections.
▼
01_corpus_ok.indd   13 26/04/2011   15:50:05
14 Archives of Cardiovascular Diseases Supplements (2011) 2, 1-91
© Elsevier Masson SAS. All rights reserved.
(1) UMR CNRS 6214 INSERM 771, biologie neurovasculaire intégrée, 
Angers, France – (2) INSERM U872, Centre de Recherche des Cordeliers, 
Universités Pierre et Marie Curie, Paris, France
Epidemiologic studies have clearly demonstrated that cardiovascular risk is 
not only determined by conventional risk factors in adult life, but also by early 
life events resulting of re-settings of physiological functions.
We previously demonstrated that in utero exposure to maternal diabetes 
induces a salt-sensitive hypertension in adult offsprings and identi¿ ed a spe-
ci¿ c gene expression pro¿ le of the thoracic aorta in favour of vasoconstric-
tion, at a pre-hypertensive stage (3 months). We found an increase of CYP4f2 
and a decrease of the prostacyclin receptor (IP) mRNA in aorta of rats exposed 
in utero to maternal diabetes (DMO) compared to rats from control mothers 
(CMO).
We now demonstrated the functional implication of these modi¿ cations in 
isolated aortic rings and conscious animals. Even before the onset of hyper-
tension (3 months), ex vivo studies showed a decreased vasodilatory function 
in response to a prostacyclin analogue (beraprost) and an increased effect of 
20-HETE acid. During in vivo experiments, we also observed a diminished 
effect of a prostacyclin analogue (iloprost, i.v., 4 ng/kg/ml) on systolic blood 
pressure (SBP) in DMO compared to CMO. Indeed, we showed that SBP 
reduction in response to iloprost was attenuated in DMO rats (-10.7% vs 
-21.3% in CMO, p<0.05). Moreover, we studied the vascular reactivity and 
of isolated carotid and mesenteric arteries of 18-months-old CMO and DMO. 
At this later stage, we found similar results, i.e. vasodilation in response to 
Beraprost was reduced in DMO, and pressure-induced (myogenic) contrac-
tion was increased.
In this study, we clearly demonstrated a fetal programming of the vessels, 
which could explain the development of hypertension and a re-setting of phy-
siological functions in adult rats exposed in utero to maternal diabetes.
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Introduction: The metabolic syndrome (MetS) is de¿ ned by the associa-
tion of different metabolic risk factors that include central obesity, elevated 
fasting glucose levels, dyslipidemia and hypertension. It has been proposed 
that these risk factors may alter blood À ow regulation in both large and small 
arteries. Thus, we hypothesized that vasoreactivity in skin microcirculation is 
altered in the MetS conditions compared to healthy controls.
Design and methods: Sixty-four subjects presenting the characteristics of 
the MetS (39 Women, 25 Men, age 59.8+/-4.8 years, BMI 33.4+/-4.2 kg.m-2) 
and twenty-one healthy normal-weight controls (11 Women, 10 Men, age 
57.47+/-3.91, BMI 22.9 +/-2.6 kg.m-2) were included. All participants were 
fasted for at the least 3 hours. Skin blood À ow was measured using single-
point Laser Doppler À owmetry, combined with iontophoresis of acetylcho-
line (Ach, endothelial-dependant vasodilatation) and sodium nitroprusside 
(SNP, endothelial-independent vasodilatation) on the ventral face of the right 
forearm.
Results: Basal skin blood À ow before iontophoresis of either Ach or SNP 
did not differ signi¿ cantly between patients with MetS and healthy controls 
(8.04+/-7.28 vs 11.03+/-9.47 PU and 8.86+/-6.12 vs 10.99+/-6.17 PU, respec-
tively). However, the peak skin blood À ow reached during iontophoresis were 
signi¿ cantly lower in MetS patients compared to healthy controls not only in 
response to Ach (41.22+/-31.56 vs 60.44+/-36.07 PU, p=0.022) but also SNP 
(66.47+/-35.73 vs 92.78+/-42.41 PU, p=0.007), respectively. 
Conclusion: Thus, MetS is characterized by marked impairments in endo-
thelial dependant and independant responses of the microcirculation small 
arteries. These severe alterations are suggestive of a decreased contribution 
of endothelial and smooth muscle activity in small skin blood À ow control.
Results: Seventy ¿ ve patients presented with metabolic syndrome and 19% 
had treated diabetes. Mean BMI was 32.1 and mean waist circumference 108 
cm. Mean adiponectin was 5.67 g/mL. The highest adiponectin concentra-
tions were associated with increased proportions of large CE-rich HDL and 
LDL particles, whereas small, dense HDL and LDL particles were found to 
be correlated with lower concentrations of adiponectin. Adiponectin was cor-
related to ApoA-I (r=0.37, p<0.001) but not with LpA-I, whereas it was cor-
related to LpA-I:A-II (r=0.29, p=0.006) and not with ApoA-II alone. No 
correlations were found with inÀ ammatory or insulin resistance markers, waist 
circumference or BMI.
Conclusions: In overweight patients, adiponectin is correlated with LDL 
and HDL distribution as well as with HDL particle composition.
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Background: Diabetic cardiomyopathy is associated with myocardial 
¿ brosis and is characterized by a silent phase of progressive left ventricular 
(LV) remodeling. In the preclinical stage, new echocardiographic techniques 
reported subtle myocardial dysfunction with a decrease in systolic strain. 
Recently, a new MRI technic, myocardial T1 mapping has been proposed to 
detect and quantify interstitial ¿ brosis.
Objective: to evaluate whether myocardial T1 mapping could detect early 
abnormalities in type 2 diabetic patients.
Methods: Type 2 asymptomatic diabetic patients with no history of heart 
disease, a normal LV ejection fraction (EF) and normal late gagolinium enhan-
cement (LGE) imaging were compared to matched healthy volunteers.
T1 quanti¿ cation was performed using a Modi¿ ed Look-Locker Inversion 
–recovery (MOLLI) sequence at 1.5T (Siemens), on a short axis of the LV 
5 and 15 min after 0.2 mmol/kg gadolinium injection. MRI protocol also 
included standard Cine-SSFP imaging, LGE imaging and regional strains 
assessment.
Results: Twenty-four diabetic patients and 16 matched volunteers were 
included.
Despite normal EF, global circumferential strain was decreased in dia-
betic patients compared to volunteers (14.6±0.3 vs. 17.0±0.4%, respectively, 
p<0.05).
Mean myocardial T1 relaxation time was signi¿ cantly shorter in diabetic 
patients than in volunteers both at 5 (312±5 vs.361±6 milliseconds, respecti-
vely, p<0.001) and 15 minutes (405±6 vs. 456±5 milliseconds, respectively, 
p<0.001) after gadolinium injection.
In conclusion: In asymptomatic type 2 diabetic T1 abnormalities are asso-
ciated with impaired myocardial strain suggesting that interstitial ¿ brosis may 
be implicated in diabetic cardiomyopathy. 
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